0
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Longitudinal dynamics of the tumor hypoxia response: From enzyme activity to biological phenotype

      review-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Poor oxygenation (hypoxia) is a common spatially heterogeneous feature of human tumors. Biological responses to tumor hypoxia are orchestrated by the decreased activity of oxygen-dependent enzymes. The affinity of these enzymes for oxygen positions them along a continuum of oxygen sensing that defines their roles in launching reactive and adaptive cellular responses. These responses encompass regulation of all steps in the central dogma, with rapid perturbation of the metabolome and proteome followed by more persistent reprogramming of the transcriptome and epigenome. Core hypoxia response genes and pathways are commonly regulated at multiple inflection points, fine-tuning the dependencies on oxygen concentration and hypoxia duration. Ultimately, shifts in the activity of oxygen-sensing enzymes directly or indirectly endow cells with intrinsic hypoxia tolerance and drive processes that are associated with aggressive phenotypes in cancer including angiogenesis, migration, invasion, immune evasion, epithelial mesenchymal transition, and stemness.

          Abstract

          Oxygen-dependent enzymes serve as sentinels to launch signal transduction in the tumor microenvironment.

          Related collections

          Most cited references185

          • Record: found
          • Abstract: found
          • Article: not found

          ROS function in redox signaling and oxidative stress.

          Oxidative stress refers to elevated intracellular levels of reactive oxygen species (ROS) that cause damage to lipids, proteins and DNA. Oxidative stress has been linked to a myriad of pathologies. However, elevated ROS also act as signaling molecules in the maintenance of physiological functions--a process termed redox biology. In this review we discuss the two faces of ROS--redox biology and oxidative stress--and their contribution to both physiological and pathological conditions. Redox biology involves a small increase in ROS levels that activates signaling pathways to initiate biological processes, while oxidative stress denotes high levels of ROS that result in damage to DNA, protein or lipids. Thus, the response to ROS displays hormesis, given that the opposite effect is observed at low levels compared with that seen at high levels. Here, we argue that redox biology, rather than oxidative stress, underlies physiological and pathological conditions. Copyright © 2014 Elsevier Ltd. All rights reserved.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing.

            HIF (hypoxia-inducible factor) is a transcription factor that plays a pivotal role in cellular adaptation to changes in oxygen availability. In the presence of oxygen, HIF is targeted for destruction by an E3 ubiquitin ligase containing the von Hippel-Lindau tumor suppressor protein (pVHL). We found that human pVHL binds to a short HIF-derived peptide when a conserved proline residue at the core of this peptide is hydroxylated. Because proline hydroxylation requires molecular oxygen and Fe(2+), this protein modification may play a key role in mammalian oxygen sensing.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Accessories to the crime: functions of cells recruited to the tumor microenvironment.

              Mutationally corrupted cancer (stem) cells are the driving force of tumor development and progression. Yet, these transformed cells cannot do it alone. Assemblages of ostensibly normal tissue and bone marrow-derived (stromal) cells are recruited to constitute tumorigenic microenvironments. Most of the hallmarks of cancer are enabled and sustained to varying degrees through contributions from repertoires of stromal cell types and distinctive subcell types. Their contributory functions to hallmark capabilities are increasingly well understood, as are the reciprocal communications with neoplastic cancer cells that mediate their recruitment, activation, programming, and persistence. This enhanced understanding presents interesting new targets for anticancer therapy. Copyright © 2012 Elsevier Inc. All rights reserved.
                Bookmark

                Author and article information

                Contributors
                Role: ConceptualizationRole: Funding acquisitionRole: MethodologyRole: Project administrationRole: SupervisionRole: VisualizationRole: Writing - original draftRole: Writing - review & editing
                Role: ConceptualizationRole: MethodologyRole: VisualizationRole: Writing - original draftRole: Writing - review & editing
                Role: ConceptualizationRole: Funding acquisitionRole: Project administrationRole: SupervisionRole: ValidationRole: Writing - original draftRole: Writing - review & editing
                Journal
                Sci Adv
                Sci Adv
                sciadv
                advances
                Science Advances
                American Association for the Advancement of Science
                2375-2548
                24 November 2023
                22 November 2023
                : 9
                : 47
                : eadj6409
                Affiliations
                [ 1 ]Princess Margaret Cancer Center, University Health Network, Toronto, Ontario, Canada.
                [ 2 ]Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada.
                [ 3 ]Department of Radiation Oncology, University of Toronto, Toronto, Ontario, Canada.
                [ 4 ]Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada.
                Author notes
                [* ]Corresponding author. Email: marianne.koritzinsky@ 123456uhn.ca
                Author information
                https://orcid.org/0000-0002-7691-8104
                https://orcid.org/0009-0000-8286-052X
                https://orcid.org/0000-0003-0547-2480
                Article
                adj6409
                10.1126/sciadv.adj6409
                10664991
                ab057d8f-fa5c-4f7f-b600-ad2eda4c974e
                Copyright © 2023 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution NonCommercial License 4.0 (CC BY-NC).

                This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial license, which permits use, distribution, and reproduction in any medium, so long as the resultant use is not for commercial advantage and provided the original work is properly cited.

                History
                : 07 July 2023
                : 23 October 2023
                Funding
                Funded by: FundRef http://dx.doi.org/10.13039/501100000023, Government of Canada;
                Award ID: Vanier Canadian Graduate Scholarship
                Funded by: FundRef http://dx.doi.org/10.13039/501100000023, Government of Canada;
                Award ID: Canadian Graduate Scholarship
                Funded by: FundRef http://dx.doi.org/10.13039/501100004376, Terry Fox Research Institute;
                Award ID: PPG19-1090
                Funded by: FundRef http://dx.doi.org/10.13039/501100004376, Terry Fox Research Institute;
                Award ID: STARS21 scholarship
                Categories
                Review
                Biomedicine and Life Sciences
                SciAdv reviews
                Cancer
                Cell Biology
                Cell Biology
                Custom metadata
                Michael Sabado

                Comments

                Comment on this article